{
    "title": "FDA pulls authorization for GSK-Vir's COVID therapy as BA.2 cases rise",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10689177/FDA-pulls-authorization-GSK-Virs-COVID-therapy-amid-rising-BA-2-cases.html",
    "date": "2022-04-05",
    "keywords": [
        "sotrovimab",
        "subvariant",
        "vir",
        "covid19",
        "ba2",
        "health",
        "glaxosmithkline",
        "therapy",
        "treatment",
        "omicron",
        "month",
        "biotechnology",
        "half",
        "regulator",
        "biotechnologys",
        "antibody",
        "country",
        "move",
        "agency",
        "authorization",
        "coronavirus",
        "government",
        "activity",
        "university",
        "filing",
        "exchange",
        "commission",
        "package",
        "use",
        "dose",
        "collaboration",
        "revenue",
        "application",
        "approval",
        "drug",
        "year",
        "latestage",
        "quarter",
        "infection",
        "spokeswoman",
        "meyer",
        "company",
        "access",
        "reporting",
        "leo",
        "bhanvi",
        "satija",
        "bengaluru",
        "editing",
        "dasgupta",
        "vinay",
        "dwivedi"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}